In the TAC model, inhibition of PTEN degradation led to AKT/mTOR inactivation and AMPK signal activation, thereby ameliorating cardiac hypertrophy and dysfunction caused by pressure overload [170]. The gene discussed is PTEN; the disease is persistent truncus arteriosus.